Volume 11, Issue 5, Pages (November 1999)

Slides:



Advertisements
Similar presentations
Volume 7, Issue 5, Pages (November 1997)
Advertisements

Volume 15, Issue 2, Pages (August 2001)
Differentiation of CD4+ T Cells to Th1 Cells Requires MAP Kinase JNK2
Volume 13, Issue 5, Pages (November 2000)
Volume 9, Issue 4, Pages (October 1998)
Volume 5, Issue 3, Pages (September 1996)
Volume 7, Issue 6, Pages (December 1997)
Volume 87, Issue 6, Pages (December 1996)
Volume 15, Issue 1, Pages (July 2001)
Volume 11, Issue 4, Pages (October 1999)
Volume 87, Issue 6, Pages (December 1996)
Volume 10, Issue 5, Pages (November 2002)
Volume 11, Issue 6, Pages (December 1999)
Balthazar B Cazac, Jürgen Roes  Immunity 
Mark H Kaplan, Ulrike Schindler, Stephen T Smiley, Michael J Grusby 
Volume 24, Issue 3, Pages (March 2006)
Jürgen Ruland, Gordon S Duncan, Andrew Wakeham, Tak W Mak  Immunity 
Impaired Development of Th2 Cells in IL-13-Deficient Mice
Volume 20, Issue 1, Pages (January 2004)
CD22 is a negative regulator of B-cell receptor signalling
Pax5/BSAP Maintains the Identity of B Cells in Late B Lymphopoiesis
Volume 23, Issue 3, Pages (September 2005)
Volume 19, Issue 4, Pages (October 2003)
Regulation of the T-Independent Humoral Response by TACI
Yang Xu, Genhong Cheng, David Baltimore  Immunity 
Defective NK Cell Activity and Th1 Response in IL-18–Deficient Mice
The Physiologic Role of CD19 Cytoplasmic Tyrosines
A Point Mutation in the Constant Region of Ig Lambda1 Prevents Normal B Cell Development due to Defective BCR Signaling  Tianhe Sun, Marcus R Clark, Ursula.
Manfred Kraus, Kaoru Saijo, Raul M Torres, Klaus Rajewsky  Immunity 
Volume 9, Issue 5, Pages (November 1998)
Volume 7, Issue 1, Pages (July 1997)
Volume 25, Issue 5, Pages (November 2006)
Volume 11, Issue 19, Pages (October 2001)
Volume 9, Issue 1, Pages (July 1998)
Volume 14, Issue 5, Pages (May 2001)
Both E12 and E47 Allow Commitment to the B Cell Lineage
Volume 6, Issue 3, Pages (March 1997)
Volume 4, Issue 4, Pages (April 1996)
Regulation of the T-Independent Humoral Response by TACI
The MAGUK Family Protein CARD11 Is Essential for Lymphocyte Activation
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Volume 9, Issue 1, Pages (July 1998)
A Prematurely Expressed Igκ Transgene, but Not a VκJκ Gene Segment Targeted into the Igκ Locus, Can Rescue B Cell Development in λ5-Deficient Mice  Roberta.
Volume 15, Issue 5, Pages (November 2001)
Impaired Development of Th2 Cells in IL-13-Deficient Mice
Volume 29, Issue 1, Pages (July 2008)
Volume 19, Issue 4, Pages (October 2003)
The MAGUK Family Protein CARD11 Is Essential for Lymphocyte Activation
Volume 16, Issue 3, Pages (March 2002)
Volume 8, Issue 1, Pages (January 1998)
Volume 10, Issue 4, Pages (April 1999)
LAT Links the Pre-BCR to Calcium Signaling
TRAF1 Is a Negative Regulator of TNF Signaling
Identification of Anergic B Cells within a Wild-Type Repertoire
Volume 23, Issue 3, Pages (September 2005)
Volume 17, Issue 3, Pages (September 2002)
Volume 10, Issue 4, Pages (April 1999)
CD83 Expression Influences CD4+ T Cell Development in the Thymus
Volume 16, Issue 3, Pages (March 2002)
Volume 9, Issue 3, Pages (September 1998)
Volume 6, Issue 4, Pages (April 1997)
Volume 4, Issue 2, Pages (February 1996)
Volume 31, Issue 5, Pages (November 2009)
Volume 10, Issue 2, Pages (February 1999)
Volume 28, Issue 1, Pages (January 2008)
Analysis of Type 2 Immunity In Vivo with a Bicistronic IL-4 Reporter
Volume 4, Issue 5, Pages (May 1996)
Volume 13, Issue 21, Pages (October 2003)
Control of B Cell Production by the Adaptor Protein Lnk
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Presentation transcript:

Volume 11, Issue 5, Pages 547-554 (November 1999) Abnormal Development and Function of B Lymphocytes in Mice Deficient for the Signaling Adaptor Protein SLP-65  Hassan Jumaa, Bernd Wollscheid, Michael Mitterer, Jürgen Wienands, Michael Reth, Peter J Nielsen  Immunity  Volume 11, Issue 5, Pages 547-554 (November 1999) DOI: 10.1016/S1074-7613(00)80130-2

Figure 1 Generation of SLP-65-Deficient Mice (A) The wild-type allele (WT), the targeting vector, and the mutated allele are shown. Black boxes represent exons (not drawn to scale). The selection cassettes, neomycin (neo), and thymidine kinase (tk), are shown as open arrows that indicate the direction of transcription. The targeting strategy was aimed at deleting exon 4 and the flanking intron sequences (hatched box). (B) A Southern blot analysis of tail DNA, digested with SacI, is shown. The blot was hybridized with the probe indicated in (A). The fragment size is shown on the right (MT, mutant; WT, wild type). (C) A Northern blot was performed on total RNA extracted from control (+/+) or mutant (−/−) splenocytes and hybridized with mouse SLP-65 cDNA (corresponding to amino acids 58–324). (D) GST-Grb2-SH3/2 precipitates were prepared from postnuclear supernatants of pervanadate/H2O2-stimulated control (+/+, lane 1) or mutant (-/-, lane 2) splenic cells. Precipitated proteins were analyzed by anti-SLP-65 immunoblotting as previously described (Wienands et al. 1998). Immunity 1999 11, 547-554DOI: (10.1016/S1074-7613(00)80130-2)

Figure 2 FACS Analysis of B Cells in Primary and Secondary Lymphoid Organs from SLP-65-Deficient Mice (A) Total cells isolated from spleen, lymph node, and peritoneal cavity of 8- to 12-week-old control (SLP-65+/+), mutant (SLP-65−/−), and B cell–deficient (μMT) mice were stained simultaneously with anti-IgD-FITC (or anti-CD5-FITC) and anti-IgM-biotin-streptavidin-R670 and analyzed by flow cytometry. Mature, immature, and transitional B cells (see Introduction for definition) are boxed and the number of cells present in each region is indicated as a percent of the total cells plotted. (B) Bone marrow cells from the three strains of mice mentioned above were similarly analyzed after staining for IgM, IgD, B220, and CD43. Again, the number of cells in the boxed regions are indicated as a percentage of the total cells plotted. Immunity 1999 11, 547-554DOI: (10.1016/S1074-7613(00)80130-2)

Figure 3 Serum Ig Concentrations and the Humoral Response in SLP-65-Deficient Mice The concentrations of serum immunoglobulin isotypes was measured by ELISA. The values for each individual control (filled circle) and deficient (open circle) mouse tested is plotted. To measure the humoral immune response, groups of five control and SLP-65-deficient mice were immunized either with the T cell–independent antigen TNP-Ficoll (B) or the T cell–dependent antigen TNP-BSA (C and D). TNP-specific IgM (B and C) or IgG (D) antibodies were measured by ELISA and the relative values (absorbance) are plotted for each individual control (filled circle) and mutant (open circle) animal. Immunity 1999 11, 547-554DOI: (10.1016/S1074-7613(00)80130-2)

Figure 4 SLP-65-Deficient Mice Show Reduced Ca2+ Mobilization and Modest Changes in the Tyrosine-Phosphoprotein Pattern after Stimulation (A) Goat anti-mouse κ antibody was added at the concentration of 20 μg/ml. Arrow 1 shows the time point of antibody addition. Arrow 2 shows the time point of ionomycin addition. The intracellular Ca2+ concentration ([Ca2+]i) is represented as the ratio of bound to unbound Indo-1. (B) Phosphotyrosine-containing proteins were affinity purified from lysates of control (lanes 1 and 2, +/+) and SLP-65-deficient (lanes 3 and 4, −/−) splenocytes stimulated with goat anti-κ antibodies. Immunity 1999 11, 547-554DOI: (10.1016/S1074-7613(00)80130-2)

Figure 5 The Proliferative Response of SLP-65-Deficient Splenocytes Is Reduced Splenocytes were cultured for 48 hr in medium alone or with soluble antibodies directed against Ig-μ, Ig-κ, or CD40. All three treatments were in the presence of IL-4. In separate cultures, cells were also incubated with LPS. Proliferation was then measured by [3H]thymidine incorporation. The mean and standard deviations are plotted for control (filled bars) and mutant (open bars) mice. The results are representative of four experiments performed. Immunity 1999 11, 547-554DOI: (10.1016/S1074-7613(00)80130-2)

Figure 6 The Architecture of the Spleen in SLP-65-Deficient Mice Is Normal Cryosections of spleen from control and SLP-65-deficient mice were stained with the indicated antibodies (labeled with FITC [green] or TRITC [red]). FDC recognizes follicular dendritic cells; anti-MAdCAM-1 stains cells in the marginal sinus of the spleen (Kraal et al. 1995); PNA (peanut agglutinin) stains germinal center B cells. Immunity 1999 11, 547-554DOI: (10.1016/S1074-7613(00)80130-2)

Figure 7 SLP-65-Mutant Mice Show Abnormal B Cell Development B cell development is schematically shown with the various stages labeled A–F (Hardy et al. 1991) or alternatively pro-B to mature B (Osmond et al. 1998). For several genes involved in BCR signaling, the stage at which mutations in these genes disturb maturation is indicated by a filled bar. Immunity 1999 11, 547-554DOI: (10.1016/S1074-7613(00)80130-2)